News & Events

MacroCure will be presented at ILSI - Biomed congress
June 2010

Dr. Mitchell Shirvan, MacroCure's CEO, will present the company during the ILSI - Biomed congress on the 16th of June, 11:00 at Hall B

 

---

Dr. Alan Smith joined MacroCure
May 2010

Alan Smith, Ph.D, Joined MacroCure as Head of US Operations
Alan has 20 years of combined experience in the biotechnology industry with the vast majority of that time spent in the cellular therapeutics area.

 

---

 

MacroCure at Conferences
May 2010

MacroCure had participated in the Bio International Convention, Chicago, May 2010 as part  of the Israel Pavilion

 

---

Over 5,000 patients treated in Israel
April 2010

Over the past 10 years, more than 5,000 patients in Israel have been treated with CureXcell™ for a variety of chronic wounds. No significant adverse events have been reported with the use of CureXcell™.